Document Detail


Preconceptional and gestational evaluation of insulin secretion in patients with polycystic ovary syndrome.
MedLine Citation:
PMID:  8981115     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The relationship between insulinaemia and obesity and glucose tolerance and the impact of pregnancy as risk factor for carbohydrate abnormalities were investigated in 91 consecutive patients with polycystic ovary syndrome (PCOS) aged 26-32 years. Fifteen normoglycaemic patients became pregnant within 6 months of the pregestational study using pharmacological induction of ovulation. Plasma concentrations of insulin and glucose after an oral glucose tolerance test (OGTT) were determined by immunoradiometric assay and glucose oxidase technique respectively. OGTT patients were classified according to their response as normoinsulinaemic (n = 46) or hyperinsulinaemic (n = 45). Impairment of glucose metabolism occurred in 12.1% (n = 11, 10 obese and one lean) of all PCOS subjects. Based on insulin secretion, 6.5% of normoinsulinaemic and 13.3% of hyperinsulinaemic patients had an impaired glucose tolerance and 2.3 and 2.2% respectively a non-insulin-dependent diabetes mellitus. Obese patients had higher values for area under the curve for insulin response to OGTT (I-AUC values) than lean patients, and the percentage above ideal body weight was greater in hyperinsulinaemic than in normoinsulinaemic patients. All hyperinsulinaemic (7/15) subjects who became pregnant developed an impairment of glucose metabolism during pregnancy. It is concluded that the PCOS population was at higher risk of developing carbohydrate abnormalities than the normal population of a similar reproductive age. Furthermore, those with abnormal insulin secretion at the pregestational stage may, during pregnancy, develop an impaired gestational glucose tolerance or gestational diabetes.
Authors:
A Lanzone; A M Fulghesu; F Cucinelli; M Guido; V Pavone; A Caruso; S Mancuso
Related Documents :
9619535 - Acute insulin response to intravenous glucagon in polycystic ovary syndrome.
7626505 - Sex hormone-binding globulin and female reproductive function.
10438405 - Alterations in cardiac flow parameters in patients with polycystic ovarian syndrome.
25308875 - Perioperative diabetes care: room for improving the person centredness.
3806025 - Lower extremity burns related to sensory loss in diabetes mellitus.
13677425 - Prevalence and determinants of diabetic retinopathy and cataracts in west african type ...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Human reproduction (Oxford, England)     Volume:  11     ISSN:  0268-1161     ISO Abbreviation:  Hum. Reprod.     Publication Date:  1996 Nov 
Date Detail:
Created Date:  1997-03-20     Completed Date:  1997-03-20     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  8701199     Medline TA:  Hum Reprod     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  2382-6     Citation Subset:  IM    
Affiliation:
Institute of Obstetrics and Gynecology, Catholic University of Sacred Heart, Rome, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Diabetes Mellitus, Type 2 / complications,  physiopathology
Female
Glucose Oxidase / metabolism
Glucose Tolerance Test
Humans
Immunoradiometric Assay
Insulin / secretion*
Obesity / physiopathology
Polycystic Ovary Syndrome / complications,  physiopathology*
Pregnancy
Pregnancy Complications / physiopathology*
Pregnancy in Diabetics / complications
Chemical
Reg. No./Substance:
11061-68-0/Insulin; EC 1.1.3.4/Glucose Oxidase

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Acarbose reduces elevated testosterone serum concentrations in hyperinsulinaemic premenopausal women...
Next Document:  Nuclear maturity and oocyte morphology after stimulation with highly purified follicle stimulating h...